Mimetas US, Inc.

MIMETAS is a worldwide leader in the cutting-edge field of Organ-on-a-Chip in vitro assays for application in pharmaceutical research and development. Our unique, proprietary OrganoPlate® technology marries advanced cellular biology with optimized microfluidic engineering. The OrganoPlate is a high-throughput, multi-channel 3D cell culture platform that simulate the activities, mechanics, and physiological response of entire organs, providing unprecedented relevance for drug discovery, safety and efficacy testing, as well as for personalized therapy selection.